A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Clinical trial NCT04917874 · COMPLETED

Trial details

NCT number: NCT04917874
Sponsor: Krystal Biotech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dystrophic Epidermolysis Bullosa DEB - Dystrophic Epidermolysis Bullosa Recessive Dystrophic Epidermolysis Bullosa Dominant Dystrophic Epidermolysis Bullosa

Start date: 2021-05-25
Primary completion: 2023-07-31
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.